<p>Ch. 1: Predictive Markers in Colon Cancer</p><p>Armin Gerger, Melissa J. LaBonte, and Heinz-Josef Lenz</p><p> </p><p>Ch. 2: Prognostic Markers in Breast Cancer</p><p>Agustin A. Garcia, and Nazish Ahmad</p><p> </p><p>Ch. 3: Predictive Markers in Lung Cancer</p><p>Stephen V. Liu, and Barbara J. Gitlitz</p><p> </p><p>Ch. 4: Prostate Cancer: Predictive Markers in Clinical Development</p><p>Courtney K. Phillips, and Daniel P. Petrylak</p><p> </p><p>Ch. 5: Biomarkers in GIST</p><p>Howard J. Lim, and Charles D. Blanke</p><p> </p><p>Ch. 6: Cytogenetic and Molecular Aberrations as Predictive Biomarkers in Acute Myeloid Leukemia</p><p>Steffen Heeg, and Cornelius F. Waller</p><p> </p><p>Ch. 7: Prognostic Markers in Colon Cancer</p><p>Janine M. Davies, and Howard L. McLeod</p><p> </p><p>Ch. 8: Markers in Lung Cancer</p><p>Edwin Y. Lin, Ravin Rupani, and Barbara J. Gitlitz</p><p> </p><p>Ch. 9: Molecular Markers of Prostate Cancer Outcome</p><p>David Ian Quinn, and Gregory P. Swanson</p><p> </p><p>Ch. 10: Prediction of Chemotherapy Toxicities</p><p>Pierre Laurent-Puig, Thierry Lecomte, Marie-Anne Loriot, Valerie Boige, and Helene Blons</p><p> </p><p>Ch. 11: Surrogate Markers—The Role of Positron Emission Tomography Scanning</p><p>Derek G. Power, and David H. Ilson</p><p> </p><p>Ch. 12: Circulating Tumor Cells as Biomarkers</p><p>Amir Goldkorn, Tong Xu, and Stephen V. Liu</p><p> </p><p>Ch. 13: Focus on Personalized Molecular Based Medicine</p><p>Lex HT Van der Ploeg, Bud Mishra, Casimir P. Eitner, Jon Burrows, Thomas Wray Tombler, Jr., Vladimir Poponin, Dan J. Knauer, Ilia Ichetovkin, Richard M. Pinnola, Gregory A. Endress, and Patrick Soon-Shiong</p><p> </p><p>Ch. 14: Clinical Validation of Biomarkers</p><p>Sumithra J. Mandrekar, and Daniel Sargent</p><p> </p><p>Ch. 15: Regulatory Issues</p><p>Maxwell T. Vergo, and Al B. Benson III</p><p> </p><p>Ch. 16: Biomarkers for Safety Assessment and Clinical Pharmacology</p><p>Stan Louie, and Jared Russell</p><p> </p><p>Ch. 17: Biomarker Discovery Strategies: DNA, RNA and Protein</p><p>Eduardo Vilar, and Josep Tabernero</p><p> </p><p>Ch. 18: Biomarkers For Go/No Go Decisions</p><p>Ben Markman, and Josep Tabernero</p><p><p> </p>
